Centessa Pharmaceuticals plc — Investor Relations & Filings
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that utilizes a Research & Development innovation engine to discover and develop transformational medicines for patients. The company employs a data-driven approach to advance its portfolio of innovative assets. A key program in its pipeline is the development of potential best-in-class, orally administered orexin receptor 2 (OX2R) agonists for the treatment of sleep-wake disorders. Centessa's broader therapeutic focus often includes rare diseases and other areas with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 3 SUBMISSION | 2021-05-28 | English | |
| FORM 3 SUBMISSION | 2021-05-28 | English | |
| FORM 3 SUBMISSION | 2021-05-28 | English | |
| Regulatory Filings 2021 | 2021-05-27 | English | |
| Regulatory Filings 2021 | 2021-05-27 | English | |
| Regulatory Filings 2021 | 2021-05-26 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 13385951 | FORM 3 SUBMISSION | 2021-05-28 | English | ||
| 13385952 | FORM 3 SUBMISSION | 2021-05-28 | English | ||
| 13385954 | FORM 3 SUBMISSION | 2021-05-28 | English | ||
| 13385955 | Regulatory Filings 2021 | 2021-05-27 | English | ||
| 13385957 | Regulatory Filings 2021 | 2021-05-27 | English | ||
| 13385956 | Regulatory Filings 2021 | 2021-05-26 | English | ||
| 32053005 | S-1/A Filing | 2021-05-26 | English | ||
| 13385958 | Regulatory Filings 2021 | 2021-05-25 | English | ||
| 13385959 | Regulatory Filings 2021 | 2021-05-25 | English | ||
| 13385960 | 8-A12B | 2021-05-25 | English | ||
| 13385961 | Regulatory Filings 2021 | 2021-05-25 | English | ||
| 13385962 | S-1/A | 2021-05-24 | English | ||
| 13385963 | Regulatory Filings 2021 | 2021-05-21 | English | ||
| 13385965 | Regulatory Filings 2021 | 2021-05-20 | English | ||
| 13385964 | Regulatory Filings 2021 | 2021-05-19 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Centessa Pharmaceuticals plc, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Centessa Pharmaceuticals plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31309/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31309 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31309 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31309 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31309}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Centessa Pharmaceuticals plc (id: 31309)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.